Methotrexate gel vs. methotrexate iontophoresis for vitiligo
Part of Skin clinical trials.
This study tests two ways of delivering methotrexate to help restore color in vitiligo patches: one uses a special gel, the other uses a mild electrical current (iontophoresis) to push the medicine into the skin. It might help if your vitiligo has been stable for at least 6 months and you haven't used other treatments recently.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have vitiligo that has been stable (no new spots or spreading) for at least 6 months.
- You are between 18 and 60 years old.
- Your vitiligo is limited to a few areas (localized or segmental) that can be treated with a cream or gel.
- You haven't used methotrexate or other vitiligo treatments (like light therapy or steroid creams) in the last 3 months.
- You are not pregnant, breastfeeding, or planning to become pregnant during the study.
- You don't have metal implants or a pacemaker, and you don't have liver, kidney, or blood problems.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether applying a methotrexate lotion after a special laser treatment (fractional CO2 laser) can help repigment vitiligo patches better than the lotion alone. The laser makes tiny holes in the skin so the medicine may absorb more deeply.
This study tests if a cream containing methotrexate (a medicine that affects the immune system) can help regrow hair in people with mild alopecia areata (patchy hair loss on the scalp). It compares the methotrexate cream to a standard treatment cream (minoxidil) to see which works better.
This study tests the drug methotrexate as a treatment for severe vulvar lichen sclerosus that has not responded to strong steroid creams. It aims to see if methotrexate can reduce symptoms and prevent further scarring.
This trial tests a new gel made from stem-cell substances (secretome) given with narrow-band UVB light therapy for stable non-segmental vitiligo. It compares two ways of applying the gel to see which works better.
This trial tests whether adding a daily nasal spray (Melanotan II) to light therapy helps restore color in stable vitiligo patches. It may be a good option for adults with mild to moderate nonsegmental vitiligo that hasn't changed in at least 6 months.
This study tests whether combining narrowband UVB light therapy with methotrexate helps treat moderate to severe plaque psoriasis. It looks at a blood marker called gelsolin to see if treatment reduces inflammation.
Hear when a new Vitiligo - Evaluation of Methotrexate Iontophoresis and Topical Methotrexate Gel as Localized Treatment Approache trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.